Author: Capital News Service

Maryland’s COVID-fighting complex

When Novavax Inc. received $1.6 billion last year from the federal government to speed up testing and production of a coronavirus vaccine, some observers were incredulous. The small biotechnology firm, based in Gaithersburg, Maryland, was largely unknown and had never successfully brought a product to market.

Read More

Support Our Work!

We depend on your support. A generous gift in any amount helps us continue to bring you this service.

MarylandReporter.com Podcast

Poll

Do you support Hogan's decision to end enhanced federal unemployment benefits?

Subscribe to Our Newsletter

Facebook